ArticlePloS one2025
First identification of ORF virus causing contagious ecthyma in Morocco (MOR20): Genomic, phylogenetic, and sequence variants analyses for vaccine design.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ORF virus induces a zoonotic contagious ecthyma disease, affecting small ruminants such as sheep and goats. ORF virus has not been identified in Morocco, and there is no vaccination protocol against contagious ecthyma. In this study, we analyzed the genome sequence of a new strain isolated in Morocco (MOR20) from a flock of sheep showing suspicious signs of Sheepox virus infection. ORFV MOR20 strain was isolated after 2 initial blind passages on Heart cells. The cytopathic effect was characterized by aggregation, swelling and detachment of cells, appearing 4 days after infection. The virus was harvested on day 6 pi with a titer of 107.2 TCID/ml. ORFV MOR20 was sequenced using the Illumina NovaSeq 6000 platform. After employing several bioinformatics tools, we identified that ORFV MOR20 shares 98.59% similarity with the TVL strain virus, which is used in a commercial live vaccine. Additionally, We aligned 33 ORFV genomic sequences with MOR20 sequences and visualized the pairwise comparisons using a Heat Map. ORFV was classified into two genetic groups: those isolated from sheep and those from goats. This was confirmed by a phylogenetic tree. Furthermore, we analyzed genetic variants identified in the MOR20 strain in comparison with ORFV TVL strain and found 636 sequence variants. Some genes, such as ORFV086, ORFV112, and ORFV132, have a particularly high number of sequence variants. All in all, ORFV MOR20 isolate represents a promising candidate for further studies aimed at developing a standardized vaccine against contagious ecthyma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.